Our technical contribution has led to a strategy for training an antibody-specific model (xTrimoPGLM-Ab) at an unprecedented scale of 100 billion parameters & 1 trillion training tokens.

xTrimoPGLM-Ab set a new record in predicting antibody naturalness & structures, both essential to the field of antibody-based drug design, & demonstrated a significantly faster inference speed than AlphaFold2.

#xTrimoPGLMAb #AlphaFold2 #bioinformatics #ProteinStructure #StructureFunction #LLM #AntibodyDesign